Credo Life Science
Posted on 27th January 2022
MUPS (Multiple Unit Pellet System) Manufacturer: Transforming Modern Drug Delivery
The Multiple Unit Pellet System (MUPS) represents a paradigm shift in oral solid dosage form design. By combining the pharmacokinetic advantages of multi-particulate systems with the manufacturing convenience of tablets, MUPS technology offers a superior drug delivery platform. Credo Life Sciences has emerged as a trusted MUPS Manufacturer, serving global pharmaceutical companies with innovative MUPS tablets and granules.
What is a Multiple Unit Pellet System (MUPS)?
A MUPS tablet contains thousands of individually coated drug-loaded pellets compressed with suitable excipients (tableting matrix) into a conventional tablet form. Upon ingestion, the tablet rapidly disintegrates, releasing the pellets which then exhibit their pre-designed release profile — enteric, extended, or immediate. MUPS combines the best of both worlds: the patient convenience of tablets and the pharmacokinetic benefits of multi-particulate pellets.
Why MUPS Technology is Superior to Conventional Formulations
Challenges in MUPS Manufacturing
Compressing enteric or extended-release coated pellets into a tablet without damaging the functional coat is the primary technical challenge in MUPS manufacturing. Pellet fracture during compression compromises the release profile, leading to bioavailability issues. A skilled MUPS Manufacturer employs carefully selected tableting excipients (cushioning agents, disintegrants), optimised compression force, and validated in-process controls to preserve pellet integrity.
Key Capabilities of a MUPS Manufacturer
- Pellet-to-Tablet Compression Expertise: Validated processes for blending pellets with cushioning matrix excipients and compressing at appropriate forces.
- Coat Integrity Testing: SEM analysis, dissolution testing at multiple pH values, and coat integrity assays confirm pellet coat remains intact post-compression.
- Process Optimisation: DoE (Design of Experiments) driven process development to optimise compression force, blend ratio, and disintegration time.
- Scalable Technology: Proven scale-up from lab to pilot to commercial scale with consistent quality outcomes.
- Regulatory Documentation: CTD-ready dossiers with full process validation, dissolution profiles, and stability data.
Credo Life Sciences as Your MUPS Manufacturer
Credo Life Sciences has invested significantly in MUPS technology — from pellet manufacturing through coating to tablet compression. Our MUPS portfolio includes Omeprazole MUPS 10/20/40 mg, Esomeprazole MUPS 20/40 mg, Pantoprazole MUPS 20/40 mg, and custom MUPS formulations for clients. Our dedicated MUPS compression lines are equipped with modern rotary tablet presses, and our QC laboratory performs comprehensive in-process and release testing.
Our MUPS Manufacturing Capabilities at a Glance
- API Pellet Manufacturing (drug layering, hot melt extrusion)
- Functional Coating (enteric, extended-release, taste masking)
- MUPS Tablet Compression (cushioned matrix with disintegrant systems)
- In-Process Control (tablet hardness, disintegration, dissolution at multiple pH levels)
- Stability Testing (ICH Zones I–IV, accelerated and long-term conditions)
As a leading MUPS Manufacturer, Credo Life Sciences brings together the science of pellet engineering and the art of tablet compression to deliver innovative drug delivery solutions. Partner with us to leverage MUPS technology for your next-generation pharmaceutical products.